Endo And Teva Are First With US Everolimus
Endo’s Par Announces Immediate Launch
Executive Summary
Patent litigation settlements have paved the way for Endo’s Par and Teva to secure the first US approvals for generic versions of Novartis’ Afinitor everolimus brand.